DHR vs JPM: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and JPMorgan Chase & Co. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
JPMorgan Chase & Co. · Financial Services
$350.13
+26.9% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
JPM |
| Current Price |
$221.12 |
$350.13 |
| Fair Value Estimate |
$286.52 |
$444.48 |
| Upside to Fair Value |
+29.6%
|
+26.9%
|
| Market Cap |
$155.4B |
$938.2B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
20.0x
|
| Price / Sales |
6.2x
|
3.1x
|
| Price / FCF |
28.5x
|
—
|
| Revenue Growth YoY |
+5.5%
|
+17.9%
|
| Gross Margin |
58.5%
|
62.6%
|
| Operating Margin |
20.4%
|
28.2%
|
| Return on Equity |
7.7%
|
17.8%
|
| Dividend Yield |
0.65% |
1.71% |
| FCF Yield |
3.51%
|
—
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
JPMorgan Chase is a diversified global bank spanning consumer banking, cards, payments, commercial banking, investment banking, markets, treasury services, and asset and wealth management, with an unusually high-quality franchise supported by funding scale, distribution, leading market positions and cross-selling across 86.6 million U.S. consumers and more than 90% of Fortune 500 companies. Busin…
Accumulation Zones
| Metric |
DHR |
JPM |
| Zone Low |
$214.89 |
$333.36 |
| Zone High |
$243.54 |
$377.81 |
| In Buy Zone? |
Yes
|
Yes
|